Literature DB >> 20621566

Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis.

Luisa M Villar1, Mercedes Espiño, María L Cavanillas, Ernesto Roldán, Elena Urcelay, Emilio G de la Concha, Maria C Sádaba, Rafael Arroyo, Pedro González-Porqué, José C Alvarez-Cermeño.   

Abstract

We described previously that multiple sclerosis (MS) patients with oligoclonal IgM against myelin lipids (M+) develop an aggressive disease. Our aim was to assess possible mechanisms regulating the production of these antibodies. We studied B cell subsets in 180 patients with MS, and 69 with other neurological diseases. M+ MS patients showed a moderate increase of CD5(+) B-cell percentage in peripheral blood and a considerable augment of these cells in cerebrospinal fluid (CSF) that correlated with intrathecal IgM production. The appearance of CD5(+) B cells into the central nervous system (CNS) was related to increased CXCL13 and TNF-alpha levels in CSF. Moreover, the presence of oligoclonal IgM associated with a SNP at position -376 of the TNF-alpha promoter. These results help to elucidate the B lymphocytes responsible for intrathecal IgM secretion in MS and the origin of this abnormal B-cell response in patients with aggressive MS.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621566     DOI: 10.1016/j.clim.2010.06.007

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  12 in total

1.  Multiple sclerosis: Genetic variability affects CNS IgG production in MS.

Authors:  Jose C Álvarez-Cermeño; Luisa M Villar
Journal:  Nat Rev Neurol       Date:  2015-04-14       Impact factor: 42.937

Review 2.  A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis.

Authors:  Soudeh Ghafouri-Fard; Kasra Honarmand; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2021-01-06       Impact factor: 3.584

3.  Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?

Authors:  Jessica Frau; Luisa Maria Villar; Claudia Sardu; Maria Antonietta Secci; Lucia Schirru; Diana Ferraro; Giancarlo Coghe; Lorena Lorefice; Giuseppe Fenu; Roberta Bedin; Patrizia Sola; Maria Giovanna Marrosu; Eleonora Cocco
Journal:  J Neurol       Date:  2017-12-22       Impact factor: 4.849

Review 4.  Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.

Authors:  Francisco J Quintana; Ada Yeste; Howard L Weiner; Ruxandra Covacu
Journal:  J Neuroimmunol       Date:  2012-05-12       Impact factor: 3.478

5.  DRB1*03:01 haplotypes: differential contribution to multiple sclerosis risk and specific association with the presence of intrathecal IgM bands.

Authors:  Emilio G de la Concha; María L Cavanillas; M Carmen Cénit; Elena Urcelay; Rafael Arroyo; Óscar Fernández; José C Álvarez-Cermeño; Laura Leyva; Luisa M Villar; Concepción Núñez
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

6.  Autologous Bone Marrow Transplantation in Multiple Sclerosis: Biomarker Relevance for Patient Recruitment and Follow up.

Authors:  Ana C Londoño; Carlos A Mora
Journal:  J Clin Cell Immunol       Date:  2016-09-20

7.  Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis.

Authors:  Carmen Picón; Amalia Tejeda-Velarde; José Ignacio Fernández-Velasco; Manuel Comabella; Roberto Álvarez-Lafuente; Ester Quintana; Susana Sainz de la Maza; Enric Monreal; Noelia Villarrubia; José Carlos Álvarez-Cermeño; María Inmaculada Domínguez-Mozo; Lluís Ramió-Torrentà; Eulalia Rodríguez-Martín; Ernesto Roldán; Yolanda Aladro; Silvia Medina; Mercedes Espiño; Jaime Masjuan; Clara Matute-Blanch; Marta Muñoz-San Martín; Carmen Espejo; Carmen Guaza; Alfonso Muriel; Lucienne Costa-Frossard; Luisa María Villar
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

Review 8.  Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?

Authors:  Maha M Bakhuraysah; Christopher Siatskas; Steven Petratos
Journal:  Stem Cell Res Ther       Date:  2016-01-16       Impact factor: 6.832

Review 9.  Feasibility and toxicity of hematopoietic stem cell transplant in multiple sclerosis.

Authors:  Thomas Low Tat Kuan; Farahnaz Amini; Marjan Sadat Seghayat
Journal:  Iran J Basic Med Sci       Date:  2017-07       Impact factor: 2.699

10.  Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients.

Authors:  Roberta Magliozzi; Valentina Mazziotti; Luigi Montibeller; Anna I Pisani; Damiano Marastoni; Agnese Tamanti; Stefania Rossi; Francesco Crescenzo; Massimiliano Calabrese
Journal:  Front Cell Neurosci       Date:  2020-10-16       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.